Latest News

  • AVI BioPharma?s Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular DystrophyFebruary 5, 2010, BOTHELL, WA
  • AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of ToxicologyFebruary 4, 2010, BOTHELL, WA
  • TMTI Accomplishments Have Advanced the Nation's Ability to Successfully Counter an Emerging BiothreatJanuary 15, 2010, BOTHELL, WA
  • Systemic Treatment with AVI-4658 Demonstrates RNA Exon Skipping and Dystrophin Protein Expression in Duchenne Muscular Dystrophy PatientsDecember 22, 2009, BOTHELL, WA
  • AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference November 19, 2009, BOTHELL, WA
  • AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry DayNovember 18, 2009, BOTHELL, WA
  • AVI BioPharma Announces Third Quarter 2009 Financial Results & Corporate HighlightsNovember 9, 2009, BOTHELL, WA
  • AVI BioPharma Announces Third Quarter 2009 Financial Results Conference CallNovember 2, 2009, BOTHELL, WA
  • AVI BioPharma Presents Updated Safety Data from Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International ConferenceOctober 26, 2009, BOTHELL, WA
  • AVI BioPharma to Present Safety Update from Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International ConferenceOctober 22, 2009, BOTHELL, WA

News Archives

  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002

Subscribe to the AVI RSS Newsfeed

About AVI BioPharma

  • Home
  • Company Overview
  • Management
  • Annual Report
  • Strategic Alliances
  • Corporate Governance

RNA Platform Technology

  • How RNA Therapeutics Work
  • Chemistry
    (PMO and its new analogs)
  • Applications (TSOs & SSOs)
  • Publications

Clinical Programs

  • Drug Pipeline
  • Duchenne Muscular Dystrophy
  • Biodefense Program

Communication

  • News
  • Events & Presentations
  • Employment
  • Contact Us

©2010 AVI BioPharma | Subscribe to our Feed